PT  - JOURNAL ARTICLE
AU  - Amy Attaway
AU  - Umur Hatipoğlu
TI  - Management of patients with COPD during the COVID-19 pandemic
AID  - 10.3949/ccjm.87a.ccc007
DP  - 2020 May 11
TA  - Cleveland Clinic Journal of Medicine
4099  - http://www.ccjm.org/content/early/2020/07/10/ccjm.87a.ccc007.short
4100  - http://www.ccjm.org/content/early/2020/07/10/ccjm.87a.ccc007.full
AB  - Patients with COPD have an increased risk for severe COVID-19. Symptoms such as high-grade fever, anorexia, and myalgia may distinguish COVID-19 from dyspnea due to a COPD-related exacerbation. Management of COVID-19 in the patient with COPD may still warrant standard-of-care exacerbation treatment with antimicrobial agents and corticosteroids. Modalities to treat acute respiratory failure can be used with some caveats. Patients with COPD and COVID-19 infection who treat their illness at home should self-isolate, use nebulizers with precautions to avoid viral aerosolization, and frequently disinfect room surfaces.